Literature DB >> 24119147

Peyronie's disease plaque calcification--prevalence, time to identification, and development of a new grading classification.

Laurence Levine1, James Rybak, Christopher Corder, Michael Ryan Farrel.   

Abstract

INTRODUCTION: Peyronie's disease (PD) is a connective tissue disorder of the penis in which a fibrous scar in the tunica albuginea can result in multiple penile deformities. AIM: The study aims to investigate the prevalence and time to identification of plaque calcification (PC) in our PD patient population and whether stratification of calcification based on severity seen on ultrasound would serve as a predictor of treatment progression to surgery.
METHODS: A retrospective review of 1,041 men presenting with PD from 1993 to 2009 was performed. Eight hundred thirty-four underwent penile duplex ultrasound. MAIN OUTCOME MEASURES: PC was graded as: grade 1 (<0.3 cm), grade 2 (>0.3 cm, <1.5 cm), grade 3 (>1.5 cm; or ≥ 2 plaques >1.0 cm). A matched control group with noncalcified plaques (n = 236) was selected for comparison.
RESULTS: Two hundred eighty-four men (34%) were found to have PC noted on ultrasound, and 98 had fully documented dimensions of the PC. Forty-one percent were found to have grade 1, 28% grade 2, and 32% grade 3. When analyzed by grade and progression to surgery, 23% of grade 1, 32% of grade 2, and 55% of grade 3 patients had surgery. Those with grade 3 PC were more likely to undergo surgical intervention for PD (OR 2.28 95% CI 1.07-4.86) and more likely to undergo a grafting procedure than control patients (P < 0.0001).
CONCLUSIONS: Men with PC are not more likely to undergo surgery than those without PC (OR 0.95, 95% CI 0.58-1.57). PC is not uncommon, as it was found in 34% of our cohort. PC does not appear to be an indication of mature or stable disease, as it was identified by ultrasound in 37% of patients less than 12 months after onset of symptoms. Men with grade 3 PC have an increased likelihood of progression to surgical intervention and a higher likelihood of undergoing a grafting procedure.
© 2013 International Society for Sexual Medicine.

Entities:  

Keywords:  Calcification; Incidence; Mature Disease; Prevalence; Severity; Tunica Albuginea Deformity

Mesh:

Year:  2013        PMID: 24119147     DOI: 10.1111/jsm.12334

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  7 in total

1.  Topical treatment for acute phase Peyronie's disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study.

Authors:  J Twidwell; L Levine
Journal:  Int J Impot Res       Date:  2015-12-24       Impact factor: 2.896

Review 2.  Surgical management of Peyronie's disease.

Authors:  Uwais B Zaid; Amjad Alwaal; Xiaoyu Zhang; Tom F Lue
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

3.  The transcriptional signatures of cells from the human Peyronie's disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets.

Authors:  Robert A Gelfand; Dolores Vernet; Istvan Kovanecz; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  J Sex Med       Date:  2014-12-11       Impact factor: 3.802

Review 4.  All about Peyronie's disease.

Authors:  Ahmed A Hussein; Amjad Alwaal; Tom F Lue
Journal:  Asian J Urol       Date:  2015-04-16

5.  Peyronie's Disease is common in poorly controlled diabetics but is not associated with the Metabolic Syndrome.

Authors:  Mohamad Habous; Ibraheem Malkawi; Esther Han; Mohammed Farag; Gordon Muir; Osama Abdelwahab; Mohammed Nassar; Saad Mahmoud; Richard Santucci; Saleh Binsaleh
Journal:  Urol Ann       Date:  2019 Jul-Sep

6.  Peyronie's disease may negatively impact the sexual experience of a couple and female sexual function: a single center study.

Authors:  Ester Illiano; Francesco Trama; Vito Mancini; Antonio Ruffo; Giuseppe Romeo; Filippo Riccardo; Consuelo Fabi; Giuseppe Carrieri; Felice Crocetto; Fabrizio Iacono; Elisabetta Costantini
Journal:  Transl Androl Urol       Date:  2021-02

7.  Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie's disease in a multicenter clinical study.

Authors:  Andrea Cocci; David Ralph; Rados Djinovic; Georgios Hatzichristodoulou; Girolamo Morelli; Andrea Salonia; Paolo Capogrosso; Andrea Romano; Gianmartin Cito; Fabrizio Di Maida; Esaú Fernández-Pascual; Javier Romero-Otero; Paulo Egydio; Marco Falcone; Mirko Preto; Giovanni Chiriacò; Jack Beck; Maarten Albersen; Suks Minhas; Giovanni Cacciamani; Juan Ignacio Martinez Salamanca; Nicola Mondani; Andrea Minervini; Giorgio Ivan Russo
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.